Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,456 | 50,814 | 37,891 | 24,086 | 12,995 |
| Depreciation Amortization | 11,626 | 36,753 | 25,048 | 15,714 | 7,505 |
| Income taxes - deferred | 127 | 3,883 | 597 | 480 | 145 |
| Accounts receivable | -1,151 | -3,842 | -1,657 | 2,031 | 2,764 |
| Other Working Capital | 2,792 | -3,594 | 1,226 | 677 | 2,507 |
| Other Operating Activity | -2,686 | -11,909 | -11,352 | -10,661 | -8,361 |
| Operating Cash Flow | $25,164 | $72,105 | $51,753 | $32,327 | $17,555 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -55,073 | -461,103 | -362,956 | -245,696 | -92,099 |
| Sale Of Investment | 10,320 | 24,886 | 24,886 | 12,642 | 8,362 |
| Other Investing Activity | 1,685 | 6,080 | 4,447 | 3,010 | 1,398 |
| Investing Cash Flow | $-43,068 | $-430,137 | $-333,623 | $-230,044 | $-82,339 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 141,500 | 558,401 | 338,300 | 221,800 | 82,500 |
| Debt Repayment | N/A | N/A | -56,270 | -2,661 | -1,497 |
| Other Financing Activity | -89,838 | -200,353 | -1,638 | -25,188 | -17,087 |
| Financing Cash Flow | $51,662 | $358,048 | $280,392 | $193,951 | $63,916 |
| Exchange Rate Effect | -243 | -331 | 234 | 437 | 321 |
| Beginning Cash Position | 14,078 | 14,393 | 14,393 | 14,393 | 14,393 |
| End Cash Position | 47,593 | 14,078 | 13,149 | 11,064 | 13,846 |
| Net Cash Flow | $33,515 | $-315 | $-1,244 | $-3,329 | $-547 |
| Free Cash Flow | |||||
| Operating Cash Flow | 25,164 | 72,105 | 51,753 | 32,327 | 17,555 |
| Capital Expenditure | -64,947 | -491,927 | -386,382 | -261,323 | -101,041 |
| Free Cash Flow | -39,783 | -419,822 | -334,629 | -228,996 | -83,486 |